Increasing array of products toease the workflow is the major factor driving the ELISAAnalyzer Market growth over the forecast period. Enzyme Linked ImmunosorbentAssay (ELISA) is a biochemical assay, which use antibodies and anenzyme-mediated color change to detect the presence of either antigen(proteins, peptides, and hormones) or antibody in sample. Enzyme-linkedimmunosorbent assay is used as diagnostic tool in medicine and analytical toolin biomedical research. ELISA analyzer is an instrument used for detecting theconcentration and presence of analyte in the test sample. ELISA analyzer can beused are a part of workflow were reagents and consumables are fed to carry outELISA and results are displayed on the screen attached to it, which is known asautomated ELISA analyzer.
Moreover, increasing prevalenceof infectious disease and drug development are also expected to fuel the ELISAanalyzer market growth over the forecast period. However, stringent regulatorypolicies for product approval are expected to hinder the new product launches,which in turn is restraining growth of the market.
ELISA Analyzer Market Dynamics
New product launches withincreased sophistication and value added testing environment to enhancesensitivity coupled with compactness of product are expected to fuel growth ofthe ELISA analyzer market over the forecast period. For instance, in 2017, SiemensHealthineers, received CE approval for Atellica Solution, an automatedimmunoassay and chemistry analyzers in Europe, the U.S., South America, andAsia.
The product has comprehensivemenu of 170 assays, which include cardiac, thyroid, and reproductive tests.Furthermore, the company has pipeline of about 50 more assays, which areexpected to be added to the present menu. In 2014, Sysmex Corporation launchedHISCL-800, a compact and automated immunoassay system used for theimmunochemistry testing. The product is claimed to be more compact as comparedto other products of same series.
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1850
ELISA technique holds promisingresults in diagnosis of health related problems. High prevalence of infectiousdisease and cancer are propelling growth of the ELISA analyzer market. Forinstance, according to World Health Organization (WHO), in 2016, an estimatedcases of malaria in 91 countries across the globe were around 216 million,which increased by 5 million as compared to 2015. Moreover, funding andinitiatives to eradicate the disease burden are expected to increase theadoption of diagnostic assay and advanced analyzer, in turn augment the ELISAanalyzer market growth.
Furthermore, increasing number ofdrug discovery programs by pharmaceutical and biopharmaceutical companies arepropelling demands for improved and advanced instrument to ease with goodquality results in less time as a part of the workflow. According toInternational Federation of Pharmaceutical Manufacturers & Associations, in2015, new 56 medicines were launched, while currently more than 7,000 compoundsare at different stages of development worldwide. Such drug discoveryprogrammes prominently use ELISA in the clinical trial, in turn increasingadoption of ELISA analyzer.
ELISA Analyzer Market - RegionalAnalysis
Regional segmentation of themarket by Coherent Market Insights includes North America, Latin America,Europe, Asia Pacific, Middle East, and Africa. North America ELISA analyzermarket holds dominant position in global market, owing to increasing burden ofinfectious disease, adoption of immunoassays in diagnosis, and presence oflocal market players. For instance, according to National Ambulatory MedicalCare Survey, 2015, in the U.S. around 16.8 million visits were reported tophysician offices for infectious and parasitic diseases.
However, Asia Pacific ELISA analyzer market is expected towitness rapid growth, owing to increasing demand from emerging economies suchas India, where large patient population demands for rapid and high-throughputtechnology for test and detection of disease.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/elisa-analyzer-market-1850
ELISA Analyzer Market –Competitive Analysis
Key players operating in theELISA analyzer market include Siemens Healthineers, Awareness Technology, Inc.,Dynes Technologies, Inc., EUROIMMUN AG, Robimes, Gold Standard Diagnostics,Corp., BioTek Instruments, Inc., and Berthold Technologies GmbH & Co. KG.
In 2016, Gold StandardDiagnostics, Corp. and R-BioPharma AG collaborated on multiple technology andmarketing initiatives to leverages respective strength of both companies toexpand product offering and geographic sales coverage. In 2013, Gold StandardDiagnostics, Corp. established distribution partnership for the ThunderBoltautomated immunoassay analyzer in 18 countries since its launch in 2012.
Key Development
In August 2019, PerkinElmer,Inc., launched EUROIMMUN Aspergillus Antigen ELISA for detection of aspergillusinfections.
In 2017, Siemens Healthineers,received CE mark for Atellica Solution, which is an automated immunoassay andchemistry analyzer and are available in the U.S., Europe, South America, andAsian markets.
In 2014, Sysmex Corporationlaunched HISCL-800, a compact and automated immunoassay system used for theimmunochemistry testing.
In 2012, Dynex Technologies Inc.,received china state food and drug administration (SFDA) approval for its DS2automated enzyme-linked immunosorbent assay (ELISA) analyzer in China. This DS2assay is considered to be an automated ELISA processing system for clinicaldiagnostic assays.
In 2012, Gold StandardDiagnostics, Corp. (GSD) launched fully automated ELISA platform thunderbolt
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1850
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
